Liraglutide changes postprandial responses of gut hormones involved in the regulation of gallbladder motility.

Henriette H NerildAndreas BrøndenIda M GetherPernille H HellmannMille BaekdalMatthew P GillumJens S SvenningsenBolette HartmannNaveen RathorHanna AngeleneJens F RehfeldJens J HolstTina VilsbøllDavid P SonneFilip K Krag Knop

Published in: Diabetes, obesity & metabolism (2023)

Compared to placebo, treatment with liraglutide decreased postprandial FGF19 and GLP-2 concentrations and increased postprandial CCK concentrations, which may explain the delayed postprandial gallbladder refilling observed in individuals with obesity treated with liraglutide. This article is protected by copyright. All rights reserved.

Keyphrases

blood glucose
metabolic syndrome
type diabetes
insulin resistance
weight loss
blood pressure
randomized controlled trial
glycemic control
body mass index
biofilm formation
physical activity
escherichia coli
double blind
cystic fibrosis
open label